The Theophylline in Dextrose Injecti, cataloged under National Stock Number 6505-01-170-7103, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Baxter Healthcare Corp IV Systems/gov Sales. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-170-7103 |
| Primary Part Number | 2B0883 |
| Item Name | Theophylline in Dextrose Injecti |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Baxter Healthcare Corp IV Systems/gov Sales |
| Status | ACTIVE |
| Administration | INTRAVENOUS INFUSION |
| Primary Container Content Quantity | 500.000 MILLILITERS |
| Primary Container Type | BAG, PLASTIC |
| Active Medicament Medicinal Strength | 400.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, V/V DEXTROSE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| 2B0883 PRIMARY | Baxter Healthcare Corp IV Systems/gov Sales (USA) |
| Reference | Meaning |
|---|---|
| NDC00338-0439-03 | 3/1 Design control — primary reference Baxter Healthcare Corp IV Systems/gov Sales |
NSN 6505-01-170-7103 is a Theophylline in Dextrose Injecti, manufactured by Baxter Healthcare Corp IV Systems/gov Sales, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-170-7103 has 1 manufacturer part number on file: 2B0883 (Baxter Healthcare Corp IV Systems/gov Sales).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-462-4616. Verify interchangeability with system specifications before substitution.
Key specifications for 2B0883: Administration: INTRAVENOUS INFUSION; Primary Container Content Quantity: 500.000 MILLILITERS; Primary Container Type: BAG, PLASTIC; Active Medicament Medicinal Strength: 400.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, V/V DEXTROSE ACTIVE INGREDIENT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.